Literature DB >> 21342705

Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.

Jing Tong1, Matthew C Zimmerman, Shumin Li, Xiang Yi, Robert Luxenhofer, Rainer Jordan, Alexander V Kabanov.   

Abstract

Fullerene, the third allotrope of carbon, has been referred to as a "radical sponge" because of its powerful radical scavenging activities. However, the hydrophobicity and toxicity associated with fullerene limits its application as a therapeutic antioxidant. In the present study, we sought to overcome these limitations by generating water-soluble nanoformulations of fullerene (C(60)). Fullerene (C(60)) was formulated with poly(N-vinyl pyrrolidine) (PVP) or poly(2-alkyl-2-oxazoline)s (POx) homopolymer and random copolymer to form nano-complexes. These C(60)-polymer complexes were characterized by UV-vis spectroscopy, infrared spectroscopy (IR), dynamic light scattering (DLS), atomic force microscopy (AFM) and transmission electron microscopy (TEM). Cellular uptake and intracellular distribution of the selected formulations in catecholaminergic (CATH.a) neurons were examined by UV-vis spectroscopy, immunofluorescence and immunogold labeling. Electron paramagnetic resonance (EPR) spectroscopy was used to determine the ability of these C(60)-polymer complexes to scavenge superoxide. Their cytotoxicity was evaluated in three different cell lines. C(60)-POx and C(60)-PVP complexes exhibited similar physicochemical properties and antioxidant activities. C(60)-poly(2-ethyl-2-oxazoline) (PEtOx) complex, but not C(60)-PVP complex, were efficiently taken up by CATH.a neurons and attenuated the increase in intra-neuronal superoxide induced by angiotensin II (Ang II) stimulation. These results show that C(60)-POx complexes are non-toxic, neuronal cell permeable, superoxide scavenging antioxidants that might be promising candidates for the treatment of brain-related diseases associated with increased levels of superoxide.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342705      PMCID: PMC3085347          DOI: 10.1016/j.biomaterials.2011.01.068

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  39 in total

1.  Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes.

Authors:  Li Xiao; Hiroya Takada; Kentaro Maeda; Mari Haramoto; Nobuhiko Miwa
Journal:  Biomed Pharmacother       Date:  2005-08       Impact factor: 6.529

2.  Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro.

Authors:  Christie M Sayes; Feng Liang; Jared L Hudson; Joe Mendez; Wenhua Guo; Jonathan M Beach; Valerie C Moore; Condell D Doyle; Jennifer L West; W Edward Billups; Kevin D Ausman; Vicki L Colvin
Journal:  Toxicol Lett       Date:  2005-10-17       Impact factor: 4.372

Review 3.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

4.  In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles.

Authors:  Naohide Shinohara; Kyomu Matsumoto; Shigehisa Endoh; Junko Maru; Junko Nakanishi
Journal:  Toxicol Lett       Date:  2009-09-20       Impact factor: 4.372

5.  A water-soluble fullerene vesicle alleviates angiotensin II-induced oxidative stress in human umbilical venous endothelial cells.

Authors:  Rui Maeda; Eisei Noiri; Hiroyuki Isobe; Tatsuya Homma; Tamami Tanaka; Kousuke Negishi; Kent Doi; Toshiro Fujita; Eiichi Nakamura
Journal:  Hypertens Res       Date:  2008-01       Impact factor: 3.872

6.  Cellular localisation of a water-soluble fullerene derivative.

Authors:  Sarah Foley; Colin Crowley; Monique Smaihi; Claude Bonfils; Bernard F Erlanger; Patrick Seta; Christian Larroque
Journal:  Biochem Biophys Res Commun       Date:  2002-05-31       Impact factor: 3.575

Review 7.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

8.  Synthetic polymeric substrates as potent pro-oxidant versus anti-oxidant regulators of cytoskeletal remodeling and cell apoptosis.

Authors:  Hak-Joon Sung; Prafulla Chandra; Matthew D Treiser; Er Liu; Carmine P Iovine; Prabhas V Moghe; Joachim Kohn
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

Review 9.  Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience.

Authors:  Eiichi Nakamura; Hiroyuki Isobe
Journal:  Acc Chem Res       Date:  2003-11       Impact factor: 22.384

10.  The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials.

Authors:  Jun-Jie Yin; Fang Lao; Peter P Fu; Wayne G Wamer; Yuliang Zhao; Paul C Wang; Yang Qiu; Baoyun Sun; Gengmei Xing; Jinquan Dong; Xing-Jie Liang; Chunying Chen
Journal:  Biomaterials       Date:  2008-11-04       Impact factor: 12.479

View more
  15 in total

1.  Distribution and biomarkers of carbon-14-labeled fullerene C60 ([(14) C(U)]C60 ) in female rats and mice for up to 30 days after intravenous exposure.

Authors:  Susan C J Sumner; Rodney W Snyder; Christopher Wingard; Ninell P Mortensen; Nathan A Holland; Jonathan H Shannahan; Suraj Dhungana; Wimal Pathmasiri; Li Han; Anita H Lewin; Timothy R Fennell
Journal:  J Appl Toxicol       Date:  2015-02-27       Impact factor: 3.446

2.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

3.  Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo.

Authors:  Jing Tong; Xiang Yi; Robert Luxenhofer; William A Banks; Rainer Jordan; Matthew C Zimmerman; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2012-12-17       Impact factor: 4.939

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 5.  Poly(2-oxazoline)s as polymer therapeutics.

Authors:  Robert Luxenhofer; Yingchao Han; Anita Schulz; Jing Tong; Zhijian He; Alexander V Kabanov; Rainer Jordan
Journal:  Macromol Rapid Commun       Date:  2012-08-03       Impact factor: 5.734

6.  Inkjet printing of insulin microneedles for transdermal delivery.

Authors:  Steven Ross; Nicolaos Scoutaris; Dimitrios Lamprou; David Mallinson; Dennis Douroumis
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

7.  Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles.

Authors:  Qihai Liu; Li Jin; Brian H Mahon; Mahendra D Chordia; Francis H Shen; Xudong Li
Journal:  Spine (Phila Pa 1976)       Date:  2013-08-01       Impact factor: 3.468

8.  Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure.

Authors:  Shekhar H Deo; James P Fisher; Lauro C Vianna; Areum Kim; Anand Chockalingam; Matthew C Zimmerman; Irving H Zucker; Paul J Fadel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

9.  Synthesis of ROS scavenging microspheres from a dopamine containing poly(β-amino ester) for applications for neurodegenerative disorders.

Authors:  Ben Newland; Paul Wolff; Dezhong Zhou; Wei Wang; Hong Zhang; Anne Rosser; Wenxin Wang; Carsten Werner
Journal:  Biomater Sci       Date:  2016-03       Impact factor: 6.843

10.  Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s.

Authors:  Anita Schulz; Sebastian Jaksch; Rene Schubel; Erik Wegener; Zhenyu Di; Yingchao Han; Annette Meister; Jörg Kressler; Alexander V Kabanov; Robert Luxenhofer; Christine M Papadakis; Rainer Jordan
Journal:  ACS Nano       Date:  2014-02-27       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.